0
總藥物數
0
低風險
0
中度風險
0
高風險

藥物清單

參考文獻

  • Obstyger. Guidance for the use of Lithium during pregnancy and the puerperium. 2024.
  • Trifu SC, et al. Affective disorders: A question of continuing treatment during pregnancy and the postpartum period. Exp Ther Med. 2020;20(3):2687-2695.
  • Women's Mental Health. SSRIs and Pregnancy: Evaluating New Reproductive Safety Data. 2015.
  • Poels EMP, et al. Lithium during pregnancy and after delivery: a review. Arch Womens Ment Health. 2018;21(6):719-730.
  • GlaxoSmithKline. The Lamotrigine Pregnancy Registry Final Report. 2010.
  • Marchocki Z, et al. A review of maternal, fetal and neonatal risks and benefits of SSRI antidepressant use in pregnancy. Arch Gynecol Obstet. 2013;288(6):1273-1279.
  • Medscape. Teratology and Drug Use During Pregnancy. 2024.
  • WHO. mhGAP-Intervention Guide Addendum on valproic acid use in women and girls of childbearing potential. 2023.
  • Canadian Paediatric Society. Selective serotonin reuptake inhibitors during pregnancy. 2021. Paediatr Child Health. 26(4):e156-e162.
  • Grover S, et al. Mood stabilizers in pregnancy and lactation. Indian J Psychiatry. 2015;57(Suppl 2):S308-S323.
  • Qiu F, et al. Effects of co-administration of lamotrigine on valproate pharmacokinetics and teratogenicity in rats. Eur J Neurosci. 2024;59(6):1532-1544.
  • Zero to Finals. Medications and Pregnancy.
  • Pinelli JM, et al. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol. 2002;187(1):245-249.
  • Macfarlane A, et al. Sodium valproate in pregnancy: what are the risks and should we use alternative drugs? BMC Pregnancy Childbirth. 2018;18(1):1-12.
  • Petrosellini C, et al. The use of psychotropic medication in the perinatal period. The Obstetrician & Gynaecologist. 2024;26(1):44-56.
  • MotherToBaby. Lithium. 2025.
  • Mayo Clinic. Antidepressants: Safe during pregnancy? 2023.
  • NHS. Pregnancy, breastfeeding and fertility while taking lithium. 2023.
  • Society for Maternal-Fetal Medicine. SMFM Statement on SSRIs and Pregnancy. 2025.
  • Choi L, et al. Olanzapine use in a manic patient during second and third trimester pregnancy. Neuropsychiatr Dis Treat. 2014;10:325-328.
  • American Addiction Centers. Benzodiazepines & Pregnancy: Safety & Effects on the Baby. 2024.
  • Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2008;36(3):518-544.
  • Tinker SC, et al. Use of benzodiazepine medications during pregnancy and potential risk for birth defects. Birth Defects Res. 2019;111(10):647-665.
  • Ji Z, et al. Antiepileptic drugs and foetal disorders: analysis of 20-year data from the FDA Adverse Event Reporting System. BMJ Open. 2025;15(2):e078089.
  • GLOWM. The Use of Psychotropic Medications During Pregnancy and Lactation. 1996.
  • Noh Y, et al. First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring. PLoS Med. 2022;19(3):e1003945.
  • The Hospitalist. Three antiseizure medications join list for newborn risks. 2024.
  • Sani G, et al. Is antipsychotic drug use during pregnancy associated with fetal growth impairment or birth defects? A systematic review and meta-analysis. Psychol Med. 2024;54(8):1521-1535.
  • McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation: a study on 854 pregnancies. Reprod Toxicol. 1994;8(6):461-475.
  • American Epilepsy Society. Some Antiseizure Medications Taken During Pregnancy Associated with Low Birth Weight in Babies. 2022.
  • NHS North West. Psychotropic Medications in the perinatal period. 2023.
  • Grigoriadis S, et al. Benzodiazepine use during pregnancy and the risk of malformations, prematurity, and fetal growth restriction: A systematic review and meta-analysis. Can J Psychiatry. 2020;65(12):821-842.
  • Leite ML, et al. Obstetric and neonatal outcomes, antiseizure medication concentrations, and breastfeeding in pregnant people with epilepsy in Brazil. PLoS One. 2024;19(3):e0291190.
  • Royal College of Psychiatrists. Antipsychotics in pregnancy and breastfeeding. 2018.
  • EMPR. Specific Antiseizure Medications Associated With Major Malformations in Infants. 2025.
  • MediResonline. Safety Profile of Benzodiazepines During Pregnancy. 2024.
  • Schmidt CT, et al. Transfer of anticonvulsants and lithium into amniotic fluid, placental tissue, and breast milk. Ther Drug Monit. 2023;45(3):381-389.
  • ADDitude Magazine. Methylphenidate, Atomoxetine Safe to Use in Pregnancy. 2025.
  • Wang H, et al. Safety and efficacy of rivastigmine and memantine combination therapy for Alzheimer's disease: a retrospective study. BMC Geriatr. 2025;25(1):78.
  • Morton A, et al. Pregnancy outcomes following first trimester exposure to semaglutide: a retrospective cohort study. Aust N Z J Obstet Gynaecol. 2025;65(3):276-281.
  • Bro SP, et al. Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy. Clin Epidemiol. 2015;7:139-147.
  • Health Canada. Acetylcholinesterase Inhibitors (AChEIs).
  • ISOM-SOMANZ. Are GLP-1 agonists teratogenic? 2024.
  • di Giacomo E, et al. Use of methylphenidate and atomoxetine in pregnancy: A systematic review and meta-analysis. JAMA Netw Open. 2024;7(11):e2444409.
  • NICE. Cholinesterase inhibitors and memantine for dementia. 2018.
  • RACGP. Unplanned pregnancy risks flagged for GLP-1s. 2025.
  • Medsafe. Methylphenidate and the risk of birth defects. 2022.
  • Youn HC, et al. The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitor on Behavioral and Psychological Symptoms of Dementia. Psychiatry Investig. 2021;18(2):141-148.
  • Parker CH, et al. Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2025;203:111742.
  • Women's Mental Health. Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications. 2023.
  • Schmidt R, et al. EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol. 2015;22(6):889-898.
  • Varughese MS, et al. GLP-1 receptor agonist therapy and pregnancy: A systematic review of maternal and neonatal outcomes. Diabetes Obes Metab. 2025;27(3):987-996.
  • ADHD Evidence.org. Nationwide population studies: atomoxetine not associated with birth defects. 2024.
  • Anne Rowling Clinic. COBALT (COmBining memantine And cholinesterase inhibitor Trial).
  • UKTIS. Use of GLP-1 receptor agonists in pregnancy. 2015.
  • Bröms G, et al. Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations. Clin Epidemiol. 2023;15:455-465.
  • NHS Specialist Pharmacy Service. Acetylcholinesterase inhibitors monitoring. 2025.
  • UK Government. Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy. 2020.
  • Women's Mental Health. Sleep Medications: What Information Do We Have on Reproductive Safety? 2015.
  • Fokina V, et al. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Am J Obstet Gynecol. 2016;215(4):497.e1-497.e7.
  • Kaplan S, et al. Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy. JAMA Intern Med. 2020;180(10):1359-1366.
  • NHS. Pregnancy, breastfeeding and fertility while taking zolpidem. 2023.
  • NHS. Pregnancy, breastfeeding and fertility while taking mirtazapine. 2022.
  • Damkier P, et al. First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations. JAMA. 2020;323(4):374-376.
  • Tu X, et al. How do you Zzz during pregnancy? A brief review of Z-drug use and management of insomnia during pregnancy. J Clin Sleep Med. 2025;21(8):1499-1502.
  • Yue M, et al. Pharmacokinetics of Antidepressants in Pregnancy. J Clin Pharmacol. 2023;63(6):636-655.
  • UKTIS. Use of modafinil in pregnancy. 2015.
  • Miller MA, et al. Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation. Chest. 2019;157(6):1506-1520.
  • Australian TGA. Medicines in pregnancy current database. 2024.
  • The Bump. Pregnancy Sleep Aid: What to Know. 2025.
  • Vickery PB, et al. Concepts for selection and utilization of psychiatric medications for pregnant and breastfeeding women. Expert Rev Neurother. 2023;23(12):1215-1234.
  • Women's Mental Health. New (But Still Not Enough) Data on Modafinil and Pregnancy. 2020.
  • Women's Mental Health. The Use of Sedative-Hypnotic Drugs During Pregnancy. 2024.
  • Bałkowiec-Iskra E, et al. Effect of antidepressants use in pregnancy on foetus and newborn. Ginekol Pol. 2017;88(1):36-42.
  • AASM. Health Canada warns that modafinil may cause fetal harm. 2020.
  • MDedge. Hypnotic Sleep Aids. 2019.
  • Paulzen M, et al. Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal serum, amniotic fluid and umbilical cord blood. J Psychiatr Res. 2020;123:85-90.
  • Chisholm CA, et al. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure. Am J Perinatol. 1997;14(9):511-513.
  • Scientific Temper. Antipsychotic medication during pregnancy and lactation.
  • Women's Mental Health. Venlafaxine and Duloxetine: Pooled Analysis Shows No Increase in Risk of Malformations. 2015.
  • [研究尚未發表] Gestational vortioxetine exposure impairs pregnancy outcomes and induces fetal neurotoxicity. 2025;40615562.
  • Ankarfeldt MZ, et al. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth. PLoS Med. 2021;18(11):e1003851.
  • Pejčić AV, et al. Outcomes of long-acting injectable antipsychotics use in pregnancy: A systematic review. Psychiatr Danub. 2024;36(1):19-33.
  • Gemoq. Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. 2021.
  • GLOWM. Teratology and Drugs in Pregnancy. 1999.
  • UKTIS. Use of haloperidol in pregnancy. 2015.
  • Islam H. Extent of Teratogenicity of Common Medications in Fetal Development: A Review. PHR thesis, BRAC University. 2021.
  • Zoega H, et al. Use of SSRI and SNRI Antidepressants during Pregnancy and Risk of Stillbirth. Harvard thesis. 2015.
  • IMC Medical. Drug Safety during Pregnancy and Breast Feeding.
  • Keilman C, et al. Oligohydramnios. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • GLOWM. Amniotic Fluid: Physiology and Assessment. 2007.
  • Plotogea M, et al. Oligohydramnios: A review of etiology and management. Romanian Journal of Medical Practice. 2022;17(4):150-157.
  • World Journal of Advanced Research and Reviews. Non-steroidal anti-inflammatory drugs induced oligohydramnios: A case report. 2025;25(02):2693-2696.
  • FDA. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. 2023.
  • [研究尚未發表] Association between borderline amniotic fluid levels and adverse perinatal outcomes in low-risk singleton pregnancies: a systematic review and meta-analysis. 2025;40693854.
  • D'Ambrosio V, et al. Use of non-steroidal anti-inflammatory drugs in pregnancy and oligohydramnios: a systematic review. J Matern Fetal Neonatal Med. 2023;36(1):2253956.
  • Kramer WB, et al. Treatment of polyhydramnios with indomethacin. Clin Perinatol. 1994;21(3):615-630.
  • Rabie N, et al. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49(4):442-449.
  • ScienceDirect. Oligohydramnios - an overview.
  • Mayo Clinic. Low amniotic fluid: Can it be treated? 2025.
  • Campbell S, et al. Fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy. BMJ Case Rep. 2017;2017:bcr2016218071.
  • Medscape. Polyhydramnios and Oligohydramnios Treatment & Management. 2025.
  • Miremberg H, et al. The association between isolated oligohydramnios at term and placental lesions: a case-control study. Placenta. 2020;89:75-80.
  • Mayo Clinic. Polyhydramnios - Diagnosis and treatment. 2023.
  • Etchecopar-Etchart D, et al. Maternal and neonatal complications of pregnant women with bipolar disorder: A systematic review and meta-analysis. EClinicalMedicine. 2025;68:102412.
  • Medscape. Polyhydramnios and Oligohydramnios Medication. 2025.
  • MSD Manuals. Problems With Amniotic Fluid. 2024.